ערך בספרים למניה: Equillium Inc (EQ)

The book value per share, based on historical data from the GURU.Markets chart, highlights the success of Equillium, Inc. (EQ) in developing immune-based drugs through alliances with biotech leaders. The 0.87 mark serves as a key metric while the company retains its scientific staff through stock option plans. Growth is driven by the integration of AI into therapy design, although final patient control remains with physicians.

For institutional investors, this metric serves as a key indicator of the assets' intrinsic value, determining the capital safety margin when assessing the attractiveness of Equillium, Inc. (EQ) shares. Analysis of the book value per share chart, which reflects the difference between total assets and liabilities per share, allows for tracking the impact of a high burn rate and FDA regulatory risks on the company's actual asset value.